Bristol-Myers Squibb Company (BMY) Foundation Marks World Hepatitis Day 2012 With New Grants Focused on Hepatitis B and Hepatitis C Patient Empowerment in China and India
7/27/2012 9:40:12 AM
NEW YORK--(BUSINESS WIRE)--The Bristol-Myers Squibb Foundation has awarded four new grants totaling US $1.69 million to improve prevention, care and support of hepatitis B (HBV) and hepatitis C (HCV) in China and India as part of its Delivering Hope™ program. The grants, announced to coincide with World Hepatitis Day on July 28, support initiatives to empower hepatitis patients to take an active role in disease management and advocacy. This focus on patient empowerment recognizes the significant health disparities that exist in these countries but also the progress that has been made to address them through disease awareness efforts and education targeted to the health care community.